Skip to main content

Peer Review reports

From: System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy

Original Submission
20 Dec 2023 Submitted Original manuscript
5 Jan 2024 Reviewed Reviewer Report
20 Jan 2024 Reviewed Reviewer Report
8 Apr 2024 Reviewed Reviewer Report
21 Apr 2024 Author responded Author comments - Yixing Huang
Resubmission - Version 2
21 Apr 2024 Submitted Manuscript version 2
22 Apr 2024 Author responded Author comments - Yixing Huang
Resubmission - Version 3
22 Apr 2024 Submitted Manuscript version 3
24 Apr 2024 Author responded Author comments - Yixing Huang
Resubmission - Version 4
24 Apr 2024 Submitted Manuscript version 4
26 Apr 2024 Author responded Author comments - Yixing Huang
Resubmission - Version 5
26 Apr 2024 Submitted Manuscript version 5
3 May 2024 Author responded Author comments - Yixing Huang
Resubmission - Version 6
3 May 2024 Submitted Manuscript version 6
Publishing
27 May 2024 Editorially accepted
4 Jun 2024 Article published 10.1186/s12891-024-07547-2

You can find further information about peer review here.

Back to article page